ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Centre Léon Bérard
Lyon, FranciaPublicacions en col·laboració amb investigadors/es de Centre Léon Bérard (7)
2020
-
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment
Investigational New Drugs, Vol. 38, Núm. 6, pp. 1774-1783
2017
-
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
European Journal of Cancer, Vol. 82, pp. 16-24
2014
2012
-
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
European Journal of Cancer, Vol. 48, Núm. 2, pp. 159-169
2011
-
Rare cancers are not so rare: The rare cancer burden in Europe
European Journal of Cancer, Vol. 47, Núm. 17, pp. 2493-2511
2010
-
The burden of rare cancers in europe
Advances in Experimental Medicine and Biology, Vol. 686, pp. 285-303
2003
-
Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Annals of Oncology, Vol. 14, Núm. 3, pp. 441-448